|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
20
|
|
pubmed:dateCreated |
2010-1-18
|
|
pubmed:abstractText |
Antithrombin-III (AT-III), the major inhibitor of thrombin in plasma, also has anti-inflammation property and might have positive effect on sepsis. The present study aimed to investigate the effects of AT-III on inflammatory reaction and pulmonary protection in endotoxin-induced acute lung injury (ALI) rat.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0366-6999
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
20
|
|
pubmed:volume |
122
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2466-71
|
|
pubmed:meshHeading |
pubmed-meshheading:20079161-Acute Lung Injury,
pubmed-meshheading:20079161-Animals,
pubmed-meshheading:20079161-Anti-Inflammatory Agents,
pubmed-meshheading:20079161-Antithrombin III,
pubmed-meshheading:20079161-Endotoxins,
pubmed-meshheading:20079161-Heparin,
pubmed-meshheading:20079161-Lung,
pubmed-meshheading:20079161-Male,
pubmed-meshheading:20079161-Mitogen-Activated Protein Kinases,
pubmed-meshheading:20079161-Rats,
pubmed-meshheading:20079161-Rats, Sprague-Dawley
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Antithrombin-III without concomitant heparin improves endotoxin-induced acute lung injury rats by inhibiting the activation of mitogen-activated protein kinase.
|
|
pubmed:affiliation |
Department of Respiratory Diseases, Clinical School of Nanjing University, Nanjing General Hospital of Nanjing Military Command, Nanjing, Jiangsu 210002, China.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
